BACKGROUND: In order to optimize care and improve outcomes in people with diabetes, adequate access to health care facilities and resources for self-management is required. METHODS: Data on 3369 individuals with type 2 diabetes who received education at 7 diabetes centers were collected prospectively between June 2005 and January 2007. The driving distances of subjects who were in good control [hemoglobin A1c (A1C) ≤7.0%] were compared with the driving distances of those who were not (A1C >7.0%). The association between A1C and improvement in A1C with travel burden was tested. RESULTS: The mean distance subjects traveled to visit their center was 13.3 miles. The results indicated that residing more than 10 miles from the diabetes management center [odds ratio (OR) = 1.91, p < .0001], being younger (OR = 0.99, p = .00015), and having a longer duration of diabetes (OR = 1.03, p = .0007) were significant contributors to a A1C >7% adjusted for individual- and community-level factors. In addition, those who lived within 10 miles of their center were 2.5 times more likely to have improved their A1C values between their first and last office visits. CONCLUSION: Health care providers should be aware of travel burden as a potential barrier to glycemic control. In the future, it may be useful to minimize driving distance for individuals with diabetes, perhaps by improved public transportation, more diabetes center locations in rural areas, telemedicine, or home visits.
BACKGROUND: In order to optimize care and improve outcomes in people with diabetes, adequate access to health care facilities and resources for self-management is required. METHODS: Data on 3369 individuals with type 2 diabetes who received education at 7 diabetes centers were collected prospectively between June 2005 and January 2007. The driving distances of subjects who were in good control [hemoglobin A1c (A1C) ≤7.0%] were compared with the driving distances of those who were not (A1C >7.0%). The association between A1C and improvement in A1C with travel burden was tested. RESULTS: The mean distance subjects traveled to visit their center was 13.3 miles. The results indicated that residing more than 10 miles from the diabetes management center [odds ratio (OR) = 1.91, p < .0001], being younger (OR = 0.99, p = .00015), and having a longer duration of diabetes (OR = 1.03, p = .0007) were significant contributors to a A1C >7% adjusted for individual- and community-level factors. In addition, those who lived within 10 miles of their center were 2.5 times more likely to have improved their A1C values between their first and last office visits. CONCLUSION: Health care providers should be aware of travel burden as a potential barrier to glycemic control. In the future, it may be useful to minimize driving distance for individuals with diabetes, perhaps by improved public transportation, more diabetes center locations in rural areas, telemedicine, or home visits.
Authors: R Turner Goins; Kimberly A Williams; Mary W Carter; Melinda Spencer; Tatiana Solovieva Journal: J Rural Health Date: 2005 Impact factor: 4.333
Authors: A V Diez-Roux; F J Nieto; C Muntaner; H A Tyroler; G W Comstock; E Shahar; L S Cooper; R L Watson; M Szklo Journal: Am J Epidemiol Date: 1997-07-01 Impact factor: 4.897
Authors: Scott Weich; Martin Blanchard; Martin Prince; Elizabeth Burton; Bob Erens; Kerry Sproston Journal: Br J Psychiatry Date: 2002-05 Impact factor: 9.319
Authors: Sumit R Majumdar; Lisa M Guirguis; Ellen L Toth; Richard Z Lewanczuk; T K Lee; Jeffrey A Johnson Journal: Diabetes Care Date: 2003-11 Impact factor: 19.112
Authors: Melanie L Davis; Brian Neelon; Paul J Nietert; Kelly J Hunt; Lane F Burgette; Andrew B Lawson; Leonard E Egede Journal: Stat Methods Med Res Date: 2017-11-16 Impact factor: 3.021
Authors: Ann P Murchison; Lisa Hark; Laura T Pizzi; Yang Dai; Eileen L Mayro; Philip P Storey; Benjamin E Leiby; Julia A Haller Journal: BMJ Open Diabetes Res Care Date: 2017-07-31
Authors: Elizabeth A Kobe; Allison A Lewinski; Amy S Jeffreys; Valerie A Smith; Cynthia J Coffman; Susanne M Danus; Elisabeth Sidoli; Beth D Greck; Leanne Horne; David R Saxon; Susan Shook; Lina E Aguirre; Mary G Esquibel; Clarene Evenson; Christopher Elizagaray; Vivian Nelson; Amanda Zeek; William G Weppner; Stephanie Scodellaro; Cassie J Perdew; George L Jackson; Karen Steinhauser; Hayden B Bosworth; David Edelman; Matthew J Crowley Journal: J Gen Intern Med Date: 2022-01-03 Impact factor: 6.473
Authors: Stephanie A Robinson; Dane Netherton; Mark Zocchi; Carolyn Purington; Arlene S Ash; Stephanie L Shimada Journal: JMIR Diabetes Date: 2021-11-19
Authors: Michael Topmiller; Jessica McCann; Jennifer Rankin; Hank Hoang; Joshua Bolton; Alek Sripipatana Journal: Fam Med Community Health Date: 2021-07
Authors: Angela D Liese; Xiaonan Ma; Lauren Reid; Melanie W Sutherland; Bethany A Bell; Jan M Eberth; Janice C Probst; Christine B Turley; Elizabeth J Mayer-Davis Journal: Pediatr Diabetes Date: 2019-02-19 Impact factor: 3.409